Vimarsana
Biggest News Aggregation in the World

B Astrazeneca News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from B Astrazeneca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In B Astrazeneca Today - Breaking & Trending Today

Twitter Files: Big Pharma pressured platform to censor COVID-19 vaccine debate - Vimarsana News

Twitter Files: Big Pharma pressured platform to censor COVID-19 vaccine debate

The pharmaceutical industry lobbied Twitter to censor posts critical of the COVID-19 vaccine, the latest batch of Elon Musk's "Twitter Files" shows.

Pfizer, BioNTech now siccing experimental COVID shots on babies - Vimarsana News

Pfizer, BioNTech now siccing experimental COVID shots on babies

Pfizer asked the FDA -- again, under an emergency use authorization -- to OK a new COVID-19-tied experimental shot, err, oops, vaccine for, get this, little kids, ages 6 months through 4 years old. Get 'em while they're young! That's the slogan of street dealers, too.

Big Pharma, WHO, globalists tee up next virus fear - Vimarsana News

Big Pharma, WHO, globalists tee up next virus fear

Sarah Gilbert, one of the creators of the Oxford-AstraZeneca coronavirus vaccines, said the next virus "could be worse. It could be more contagious, or more lethal, or both," Reuters reported. No dip, Sherlock. The next one could be tame, too. Or lame. Or completely unnoticeable.

French drugmaker Valneva reports positive COVID-19 vaccine results - Vimarsana News

French drugmaker Valneva reports positive COVID-19 vaccine results

A French drugmaker said Monday its COVID-19 shots staved off disease and produced more robust immunity than a rival vaccine, meaning that shots that rely on conventional technology could enter the global pipeline.

French drugmaker Valneva reports positive COVID-19 vaccine results - Vimarsana News

French drugmaker Valneva reports positive COVID-19 vaccine results

A French drugmaker said Monday its COVID-19 shots staved off disease and produced more robust immunity than a rival vaccine, meaning that shots that rely on conventional technology could enter the global pipeline.